Literature DB >> 2567438

Peptide regulatory factors in non-malignant disease.

G W Duff1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2567438     DOI： 10.1016/s0140-6736(89)90134-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease.

Authors:  Y R Mahida; A Gallagher; L Kurlak; C J Hawkey
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

Review 2.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

3.  Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis.

Authors:  M Rooney; J A Symons; G W Duff
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 4.  Asian-Indians: a review of coronary artery disease in this understudied cohort in the United States.

Authors:  Devarshi R Ardeshna; Tamunoinemi Bob-Manuel; Amit Nanda; Arindam Sharma; William Paul Skelton; Michelle Skelton; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

5.  Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.

Authors:  A I Blakemore; A Cox; A M Gonzalez; J K Maskil; M E Hughes; R M Wilson; J D Ward; G W Duff
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

6.  Tumour necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity.

Authors:  G T Espersen; M Vestergaard; E Ernst; N Grunnet
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

7.  Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus.

Authors:  F E Clay; M J Cork; J K Tarlow; A I Blakemore; C I Harrington; F Lewis; G W Duff
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

8.  Effects of interleukin-1 beta on insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes.

Authors:  T Matsumoto; T Tsukazaki; H Enomoto; K Iwasaki; S Yamashita
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

9.  Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).

Authors:  Sotirios Tsimikas; Gordon W Duff; Peter B Berger; John Rogus; Kenneth Huttner; Paul Clopton; Emmanuel Brilakis; Kenneth S Kornman; Joseph L Witztum
Journal:  J Am Coll Cardiol       Date:  2014-02-12       Impact factor: 24.094

10.  Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes.

Authors:  T Takebayashi; M Iwamoto; A Jikko; T Matsumura; M Enomoto-Iwamoto; F Myoukai; E Koyama; T Yamaai; K Matsumoto; T Nakamura
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.